www.fdanews.com/articles/67889-dharmacon-rnai-technology-selected-to-support-drug-discovery-research
Dharmacon RNAi Technology Selected to Support Drug Discovery Research
January 24, 2005
Dharmacon, a leading supplier of innovative RNA and RNA interference (RNAi) research products, has announced that Genentech has selected Dharmacon's advanced RNAi technology for use in its drug discovery and development research.
Under an agreement between the two companies, Dharmacon will supply Genentech
with a range of siRNA reagents including Dharmacon's Human Druggable Genome
library, which focuses on those genes that are considered potential targets
for therapeutics.